Last reviewed · How we verify
Influenza HA vaccine "Biken HA"
Influenza HA vaccine "Biken HA" is a Biologic drug developed by Nitto Denko Corporation. It is currently in Phase 1 development.
At a glance
| Generic name | Influenza HA vaccine "Biken HA" |
|---|---|
| Sponsor | Nitto Denko Corporation |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Influenza HA vaccine "Biken HA" CI brief — competitive landscape report
- Influenza HA vaccine "Biken HA" updates RSS · CI watch RSS
- Nitto Denko Corporation portfolio CI
Frequently asked questions about Influenza HA vaccine "Biken HA"
What is Influenza HA vaccine "Biken HA"?
Influenza HA vaccine "Biken HA" is a Biologic drug developed by Nitto Denko Corporation.
Who makes Influenza HA vaccine "Biken HA"?
Influenza HA vaccine "Biken HA" is developed by Nitto Denko Corporation (see full Nitto Denko Corporation pipeline at /company/nitto-denko-corporation).
What development phase is Influenza HA vaccine "Biken HA" in?
Influenza HA vaccine "Biken HA" is in Phase 1.